Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 16, 2014
Entry time effects and follow-on drug competitionLuiz Flavio Andrade, Catherine Sermet, Sylvain PichettiHealth Policy (Amsterdam, Netherlands)|August 2, 2011
Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: a time-series analysis for France 1998-2010Sylvain Pichetti, Christine Sorasith, Catherine SermetEuropean Journal of Clinical Pharmacology|June 12, 2017
Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French populationMarie Herr, Nicolas Sirven, Hélène Grondin, et al.Applied Health Economics and Health Policy|April 24, 2013
Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in FranceSylvain Pichetti, Catherine Sermet, Brian Godman, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 4, 2016
Exploring the determinants of endocrinologist visits by patients with diabetesLuiz Flavio Andrade, Thomas Rapp, Christine Sevilla-DedieuCommunity Mental Health Journal|December 21, 2013
Factors influencing report of common mental health problems among psychologically distressed adultsMyriam Khlat, Stéphane Legleye, Catherine SermetPharmacoeconomics|January 9, 2020
A French Value Set for the EQ-5D-5LLuiz Flavio Andrade, Kristina Ludwig, Juan Manuel Ramos Goni, et al.European Journal of Epidemiology|July 6, 2004
Increased prevalence of depression, smoking, heavy drinking and use of psycho-active drugs among unemployed men in FranceMyriam Khlat, Catherine Sermet, Annick Le PapePresse Medicale (Paris, France : 1983)|March 3, 2007
[Cost of obesity in France]Corinne Emery, Jérôme Dinet, Antoine Lafuma, et al.Pageof 3